Serrétia’s Use for Sport Injuries

NSAID’s do an effective job of masking the pain and inflammation of an injury, however merely masking the aforementioned symptoms, may prolong recovery.* The use of systemic enzymes such as Serrétia, may provide an additional choice for supporting normal recovery.* Serrétia works by digesting any dead tissue that may accumulate as a result of an injury, which then allows normal fluid retention to take place, thereby aiding in a normal inflammatory response, while assisting one’s ability to heal.*

Studies on Sport Injuries:

In Europe the overall use of systemic enzymes has been far more widespread than in the United States. In Germany in particular, systemic enzymes have been actively used for decades and are even used by the German National Hockey to support physical health.*

German Dr. M. W. Kleine and his team at the Sports Medicine Investigation Center in Grumwald, Germany, decided to look at 100 athletes in order to determine the ‘effectiveness of proteolytic enzymes’. Dr. Kleine took each subject and removed two cubic cm of blood from their anticubital vein. By reinserting the blood under the skin on each subject’s right forearm, Dr. Kleine and his team were able to reproduce a hematoma (blood clot). 50 of the subjects were then given placebo pills, while the other 50 subjects were given proteolytic enzymes; each subject taking one pill three times a day. The results speak for themselves: 35 or 70% of the 50 subjects that had been treated with enzymes reported considerably less discomfort, normal inflammation, a shorter lasting amount of discomfort on pressure and had the hematoma disappear in a shorter amount of time than their placebo counterparts.*

Preventative Uses for Serrétia:

Serrétia can also be successfully used in order to support normal injury recovery times. In another German study researchers set out to discover how well serrapeptase could assuage the discomfort of subjects who have undergone surgery.*

The German study involved sixty-six subjects that had undergone surgery in order to treat the rupture of the knee ligament, which is often suffered by athletes and causes substantial discomfort and inflammation. The subjects were split into two groups; one of which took serrapeptase, while the other was given a placebo. Three days following the surgery, the subjects that were given serrapeptase were found to have a 50% reduction of inflammation and experienced less discomfort compared to their placebo counterparts.*